Tirofiban Hydrochloride is the hydrochloride salt form of tirofiban, a non-peptide tyrosine derivative with anticoagulant property. Tirofiban antagonizes fibrinogen binding to the platelet cell surface receptor, glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP. The antagonism prevents adenylyl cyclase activation, which mediated via GP IIb/IIIa receptor complex, and results in decreased levels of cAMP and thereby interferes with platelet membrane function and subsequent platelet-platelet interaction, release of platelet granule constituents and prolongation of bleeding time. It is grouped under the following drug class(es): Antiplatelets and Antithrombotic agents. Its therapeutic use is listed as hematologic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Aggrastat and Tirofiban HCl. Its PubChem CID is 64781.
Tirofiban hydrochloride
| CAS No | 142373-60-2 |
|---|---|
| Molecular Formula | C22H37ClN2O5S |
| Molecular Weight | 477.1 g/mol |
| Synonyms | (2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Tirofiban Hydrochloride is the hydrochloride salt form of tirofiban, a non-peptide tyrosine derivative with anticoagulant property. Tirofiban antagonizes fibrinogen binding to the platelet cell surface receptor, glycoprotein (GP) IIb/IIIA complex, one of the two purinergic receptors activated by ADP.
The listed CAS number is 142373-60-2.
The listed molecular formula is C22H37ClN2O5S.
The listed molecular weight is 477.1 g/mol.
(2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid;hydrochloride.
The source lists Aggrastat and Tirofiban HCl.